HE standard of care for the management of postcraniotomy wound infections consists of operative debridement and removal of the devitalized bone flap followed by delayed cranioplasty performed several months later. 1, 5, [8] [9] [10] 17 This strategy, although successful in treating most infections, adversely affects patient satisfaction by necessitating an additional surgical procedure for cranioplasty, as well as leaving a cosmetic deformity and lack of brain protection before cranioplasty can be performed. Methods to address this difficulty such as the suction-irrigation treatment of craniotomy infections are laborious and are associated with a failure rate of 40%. 4, 6 We have instituted a surgical debridement strategy to treat postcraniotomy wound infections that allows preservation of bone flaps to obviate the need for an additional operation for cranioplasty. We report highly favorable results with long-term follow-up evaluations after using this strategy in a prospective cohort of consecutive patients with postcraniotomy infections. The favorable results invite a reexamination of the common practice of discarding bone flaps in patients undergoing operative debridement.
lococci or by Propionibacterium acnes. Three patients had Gram-negative bacilli infections, including two patients who had undergone skull base procedures. In one patient no organism was isolated.
Treatment Methods
Standard operative debridement consisted of reopening of the wound and reelevation of the bone flap. All visible suture material and hemostatic agents were removed. The purulent material was cultured and analyzed for anaerobic and aerobic organisms, as well as for antibiotic sensitivities. Necrotic and purulent debris were removed by mechanical debridement and copious irrigation with bacitracin solution followed by saline. The bone flap was vigorously scrubbed and soaked in Betadine solution. In no instance was the bone flap autoclaved and the bone edges were not routinely drilled. Hemostastis was achieved with the aid of bipolar cautery and a hemostatic agent such as Avitene (Avicon, Inc., Fort Worth, TX) or FloSeal (Fusion Medical Technologies, Inc., Fremont, CA), which subsequently could be irrigated out of the area. Bulky hemostatic agents such as Gelfoam (Upjohn Corp., Kalamazoo, MI) were avoided as much as possible to reduce the amount of foreign material remaining in the wound. The bone flap was then plated or wired back into place and the wound was again approximated in a routine fashion by using 3-0 vicryl and staples or 3-0 nylon. Drains were not routinely left in place.
Patients were treated with broad-spectrum intravenous antibiotic agents until determination of the intraoperative tissue cultures and antibiotic sensitivities, after which time the antibiotics regimen was adjusted accordingly. A full course of systemic antibiotic agents was administered according to the recommendations of an infectious disease consultant in each case. In most cases this consisted of 1 week of intravenous therapy followed by 2 to 4 weeks of oral therapy. The patients were followed up on a long-term basis for signs of recurrent infection. This long-term follow up ranged from 8 to 77 months (mean 35 months). Follow up was limited in Cases 7, 8, and 13 because the patients died of malignant tumor progression.
Results
Among the 13 patients who underwent open debridement, the bone flap was preserved with complete resolution of infection in all but two patients (Table 1) . Due to the nature of the senior author's surgical practice, the majority of patients suffered from neurooncological conditions. As such, many had risk factors for recurrent infection and poor wound healing, including prior surgery, radiotherapy, chemotherapy, and skull base procedures. Most importantly, in the five patients with no risk factors, bone flap preservation was possible without complication or the need for any additional surgery. Of the 11 patients in whom the bone flap was preserved, two patients required wound revisions for wound healing problems associated with several risk factors ( Table 2 ). The indications for wound revisions were minor and consisted of wound dehiscence in one patient (Case 10) in whom soft-tissue viability had been compromised by prior surgery and radiotherapy; and giant cell reaction confined to the dermis, which was probably due to an allergic reaction to vicryl sutures, in another patient (Case 13) who had previously undergone radiation treatment for a primitive neuroectodermal tumor. In the two patients in whom bone flap removal was ultimately necessary because of recurrent infection (Cases 11 and 12), this occurred after 2 months in one patient, but not until a lengthy delay of 29 months in the other. These two patients shared several risk factors for poor wound healing, the most notable being that they had undergone craniofacial procedures through an anterior skull base osteotomy for anterior skull base tumors involving communication with the nasal sinuses. Additionally, one patient had undergone previous tumor resection and the other had completed postoperative radiotherapy.
It is notable that many patients were successfully treated with bone flap preservation, despite their risk factors. Of the eight patients with one or more risk factors, four were treated without any further procedures, whereas two (Cases 10 and 13) required minor wound revisions with bone flap preservation and another two (Cases 11 and 12) ultimately underwent an additional surgical procedure and bone flap removal for recurrent infections. Of five patients who had received radiotherapy, two were treated without an additional surgical procedure, two required minor wound revisions, and only one ultimately required bone flap removal. A history of craniotomy for recurrent tumor was relevant in four patients, including one who required a minor second wound revision and one in whom the bone flap was discarded only after an infection developed 29 months later. Of two patients with a history of chemotherapy, neither required wound revision. Three patients underwent skull base surgeries: one patient in whom a presigmoid approach had been made to a petrous apex meningioma and the clinical course was uncomplicated (Case 9), and two patients who underwent craniofacial surgery, in whom ultimately bone preservation was not possible (Cases 11 and 12 ).
Nearly all patients had infections secondary to skin organisms, with staphylococcus and Propionibacterium acnes being the most common. One patient had experienced an initial Gram-negative bacillary infection due to K. pneumoniae; this was the patient whose bone flap was removed after a 29-month delay (Case 11) because of an infection caused by K. pneumonia and Pseudomonas aeruginosa. Two other patients had infections due to E. aerogenes, including one with a mixed E. aerogenes-Proteus mirabilis infection, most likely due to involvement of the mastoid sinus following a transpetrosal approach (Case 9).
Discussion
Since 1990, we have had a postcraniotomy infection rate of 1.1%, which compares favorably with average rates reported in large series, which range from less than 1% to as high as 11% in patients with recurrent malignant gliomas. 2, 3, 7, 8, 14, 18 We have prospectively managed all postcraniotomy wound infections with operative debridement and preservation of bone flaps. Although this series is relatively small, it spans more than a decade and demonstrates that simple operative debridement is sufficient in patients with uncomplicated postcraniotomy infections, making it unnecessary to discard bone flaps and perform cranioplasties. Even patients with risk factors such as prior surgery, skull base procedures, chemotherapy, or radiotherapy can be successfully treated using this strategy in most cases. Patients with craniofacial surgeries involving the nasal sinuses, however, are at higher risk and might be best treated with bone flap removal and delayed cranioplasty.
The methods used for surgical debridement and delivery of systemic antibiotic agents to facilitate bone flap preservation are straightforward. Aggressive operative debridement with elevation of the bone flap and antibiotic irrigation to remove all dead tissue, debris, suture, and foreign material is desirable. The bone flap is vigorously scrubbed before replating it in place. Additionally it is reasonable to avoid leaving an excess of bulky hemostatic agents. FloSeal or Avitene are reasonable choices; they can be irrigated away after hemostasis has been achieved. Finally a full course of specific systemic antibiotics is indicated, based on determination of the bacterial cultures and antibiotic sensitivities.
Traditionally, the management of postoperative infections has consisted of operative debridement and removal of devitalized bone flaps followed by delayed cranioplasty. 1, 5, [8] [9] [10] 17 A management strategy that preserves the bone flap has the obvious advantage of avoiding the cost and inconvenience of an additional operative procedure for cranioplasty and the ensuing decreased patient satisfaction from the sizeable cosmetic defect and lack of brain protection during the several months before cranioplasty can be safely performed. Previously Chou and colleagues 4, 6 reported having modest success with the suction-irrigation method of wound management. In their report of 25 patients success was achieved in 60%, although the follow-up period was not lengthy. 4 This laborious and inconvenient method necessitated daily antibiotic irrigation through subgaleal drains over a 5-day period. The lack of success was likely due to insufficient operative debridement because the bone flaps were not reelevated. Additionally, the use of drains for an extended period of time may have contributed to the risk of reinfection. 16, 19 Based on our results, we conclude that additional irrigation is superfluous following vigorous surgical debridement. Other reports justify the rationale for bone flap preservation by describing anecdotal successes follow- ing bone flap debridement alone 3, 8, 11 or preservation of hydroxyapatite 13 and primary wire mesh cranioplasties 15 at the initial surgical debridement.
A variety of risk factors are known to be associated with postcraniotomy wound infections, including cerebrospinal fluid leak, prior craniotomies, radiotherapy, and craniofacial procedures involving the nasal sinuses. [2] [3] [4] 8, 12, 14, 16 These factors, particularly prior radiotherapy and craniofacial procedures, are also likely to be associated with repeated infection following initial surgical debridement. 4 The small number of patients involved in this series makes it difficult to generalize and stratify patients with significant risk factors for infection and poor wound healing; however, all patients in this series who had no risk factors had full resolution of their infection after a single operative debridement. This suggests that patients with benign pathological conditions and uncomplicated histories can be treated with bone flap preservation, including those patients who have initially undergone craniotomies for vascular malformations, aneurysms, tumors, or seizures. No patient in this series had suffered trauma and thus it is difficult to speculate on the likelihood of success when nonendogenous bacteria have potentially contaminated the wound. The nature of the referral practice analyzed in this series was heavily weighted toward neurooncology and, therefore, a sizeable percentage of patients had undergone prior craniotomies for recurrent tumors, as well as radiotherapy and chemotherapy. Interestingly, even patients with these risk factors were successfully treated with bone flap preservation. Although two of the eight patients with risk factors required subsequent wound revisions for poor wound healing, it did not appear that removal of the bone flap would have prevented a revision, because their wound healing was compromised by a giant cell dermal reaction or a radiation-induced wound dehiscence.
The most obvious risk factor predictive of ultimate bone flap removal is anterior skull base lesions in patients who have undergone craniofacial procedures involving communication with the nasal sinuses. 4, 16 Interestingly, one of the patients in this category (Case 11) was initially treated successfully, but required an additional operation 29 months later. In such an anecdotal case it is difficult to determine if bone flap removal would have ultimately prevented this infection recurrence. The patient's clinical history was also complicated by her having undergone previous surgery and having a Gram-negative rod infection (K. pneumoniae), a more virulent organism than most skin bacteria. 8 The other treatment failure in a patient who underwent surgery (Case 12) was complicated by radiotherapy. Therefore, although a craniofacial procedure involving the nasal sinuses is a significant risk factor, it is possible that patients with infections whose histories are uncomplicated by radiotherapy or prior surgery may still be successfully treated with bone flap preservation. It is difficult to generalize pessimistically about all patients with skull base lesions because the one patient in this series who underwent a temporal craniotomy and a transpetrosal approach had an uncomplicated antibiotic course, despite the fact that there was communication with mastoid air cells.
The success of this treatment strategy argues for a change in the standard of care for patients with uncomplicated postcraniotomy wound infections. The results reported here will benefit from verification in larger numbers of patients by other neurosurgeons. Although treatment failures and subsequent bone flap removals will be inevitable as the number of patients increases, the substantial benefits afforded by this approach justify its use for the majority of patients in whom success is likely. Risk factors such as prior surgery, radiotherapy, or skull base approaches may adversely affect outcome and, although not absolute contraindications, should be candidly evaluated and discussed with individual patients before operative debridement is undertaken.
Conclusions
We report the highly favorable results of a prospective study in which aggressive surgical debridement was performed to preserve bone flaps without cranioplasty in patients who had postcraniotomy wound infections. In these patients, simple operative debridement was sufficient and it was unnecessary to discard bone flaps and perform cranioplasties. The substantial benefits to patients of bone flap preservation include avoidance of a temporary, large, cosmetic craniotomy defect over the unprotected brain as well as an additional surgical procedure for cranioplasty. Even patients who have undergone previous surgery, radiotherapy, skull base procedures, or chemotherapy may be successfully treated using this strategy, although they carry a higher risk. The only risk factor strongly correlated to lack of success is a prior craniofacial procedure involving communication with the nasal sinuses.
